-
1
-
-
0036699940
-
Molecular pathogenesis of human hepatocellular carcinoma
-
Thorgeirsson S.S., Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 2002, 31:339-346.
-
(2002)
Nat. Genet.
, vol.31
, pp. 339-346
-
-
Thorgeirsson, S.S.1
Grisham, J.W.2
-
2
-
-
0024206625
-
Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element
-
Norman C., Runswick M., Pollock R., Treisman R. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell 1988, 55:989-1003.
-
(1988)
Cell
, vol.55
, pp. 989-1003
-
-
Norman, C.1
Runswick, M.2
Pollock, R.3
Treisman, R.4
-
3
-
-
0032476590
-
Serum response factor is essential for mesoderm formation during mouse embryogenesis
-
Arsenian S., Weinhold B., Oelgeschlager M., Ruther U., Nordheim A. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J 1998, 17:6289-6299.
-
(1998)
EMBO J
, vol.17
, pp. 6289-6299
-
-
Arsenian, S.1
Weinhold, B.2
Oelgeschlager, M.3
Ruther, U.4
Nordheim, A.5
-
4
-
-
3042588831
-
Molecular regulation of vascular smooth muscle cell differentiation in development and disease
-
Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801.
-
(2004)
Physiol. Rev.
, vol.84
, pp. 767-801
-
-
Owens, G.K.1
Kumar, M.S.2
Wamhoff, B.R.3
-
5
-
-
5644293131
-
Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors
-
Lockman K., Hinson J.S., Medlin M.D., Morris D., Taylor J.M., Mack C.P. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors. J. Biol. Chem. 2004, 279:42422-42430.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 42422-42430
-
-
Lockman, K.1
Hinson, J.S.2
Medlin, M.D.3
Morris, D.4
Taylor, J.M.5
Mack, C.P.6
-
6
-
-
66149117384
-
Hepatocyte expression of serum response factor is essential for liver function, hepatocyte proliferation and survival, and postnatal body growth in mice
-
Sun K., Battle M.A., Misra R.P., Duncan S.A. Hepatocyte expression of serum response factor is essential for liver function, hepatocyte proliferation and survival, and postnatal body growth in mice. Hepatology 2009, 49:1645-1654.
-
(2009)
Hepatology
, vol.49
, pp. 1645-1654
-
-
Sun, K.1
Battle, M.A.2
Misra, R.P.3
Duncan, S.A.4
-
7
-
-
38449102928
-
Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition
-
Park M.Y., Kim K.R., Park H.S., et al. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition. Int. J. Oncol 2007, 31:1309-1315.
-
(2007)
Int. J. Oncol
, vol.31
, pp. 1309-1315
-
-
Park, M.Y.1
Kim, K.R.2
Park, H.S.3
-
8
-
-
11144252700
-
Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways
-
Shao R.X., Otsuka M., Kato N., et al. Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways. Gastroenterology 2005, 128:86-95.
-
(2005)
Gastroenterology
, vol.128
, pp. 86-95
-
-
Shao, R.X.1
Otsuka, M.2
Kato, N.3
-
9
-
-
36248947214
-
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade
-
Grassi G., Scaggiante B., Farra R., et al. The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade. Biochimie 2007, 89:1544-1552.
-
(2007)
Biochimie
, vol.89
, pp. 1544-1552
-
-
Grassi, G.1
Scaggiante, B.2
Farra, R.3
-
10
-
-
60249101252
-
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, P21 and P27 levels
-
Baiz D., Pozzato G., Dapas B., et al. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, P21 and P27 levels. Biochimie 2009, 91:373-382.
-
(2009)
Biochimie
, vol.91
, pp. 373-382
-
-
Baiz, D.1
Pozzato, G.2
Dapas, B.3
-
11
-
-
38649101592
-
Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose
-
Zanetti M., Stocca A., Dapas B., et al. Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose. J. Mol. Med 2008, 86:185-195.
-
(2008)
J. Mol. Med
, vol.86
, pp. 185-195
-
-
Zanetti, M.1
Stocca, A.2
Dapas, B.3
-
12
-
-
25444494901
-
Quantification strategies in real-time PCR
-
International University Line, (IUL), La Jolla, CA, USA, S.A. Bustin (Ed.)
-
Pfaffl M.W. Quantification strategies in real-time PCR. A-Z of Quantitative PCR 2004, International University Line, (IUL), La Jolla, CA, USA. S.A. Bustin (Ed.).
-
(2004)
A-Z of Quantitative PCR
-
-
Pfaffl, M.W.1
-
13
-
-
0025742603
-
The serum response factor is extensively modified by phosphorylation following its synthesis in serum-stimulated fibroblasts
-
Misra R.P., Rivera V.M., Wang J.M., Fan P.D., Greenberg M.E. The serum response factor is extensively modified by phosphorylation following its synthesis in serum-stimulated fibroblasts. Mol. Cell Biol. 1991, 11:4545-4554.
-
(1991)
Mol. Cell Biol.
, vol.11
, pp. 4545-4554
-
-
Misra, R.P.1
Rivera, V.M.2
Wang, J.M.3
Fan, P.D.4
Greenberg, M.E.5
-
14
-
-
0042972933
-
Activation of the interferon system by short-interfering RNAs
-
Sledz C.A., Holko M., de Veer M.J., Silverman R.H., Williams B.R. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 2003, 5:834-839.
-
(2003)
Nat. Cell Biol.
, vol.5
, pp. 834-839
-
-
Sledz, C.A.1
Holko, M.2
de Veer, M.J.3
Silverman, R.H.4
Williams, B.R.5
-
15
-
-
0029986337
-
Regulation of cyclin E transcription by E2Fs and retinoblastoma protein
-
Geng Y., Eaton E.N., Picon M., et al. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 1996, 12:1173-1180.
-
(1996)
Oncogene
, vol.12
, pp. 1173-1180
-
-
Geng, Y.1
Eaton, E.N.2
Picon, M.3
-
16
-
-
18844381179
-
Proteasome: an emerging target for cancer therapy
-
Zavrski I., Jakob C., Schmid P., et al. Proteasome: an emerging target for cancer therapy. Anticancer Drugs 2005, 16:475-481.
-
(2005)
Anticancer Drugs
, vol.16
, pp. 475-481
-
-
Zavrski, I.1
Jakob, C.2
Schmid, P.3
-
17
-
-
0038419800
-
Induction of an interferon response by RNAi vectors in mammalian cells
-
Bridge A.J., Pebernard S., Ducraux A., Nicoulaz A.L., Iggo R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 2003, 34:263-264.
-
(2003)
Nat. Genet.
, vol.34
, pp. 263-264
-
-
Bridge, A.J.1
Pebernard, S.2
Ducraux, A.3
Nicoulaz, A.L.4
Iggo, R.5
-
18
-
-
4043163461
-
E2F target genes: unraveling the biology
-
Bracken A.P., Ciro M., Cocito A., Helin K. E2F target genes: unraveling the biology. Trends Biochem. Sci. 2004, 29:409-417.
-
(2004)
Trends Biochem. Sci.
, vol.29
, pp. 409-417
-
-
Bracken, A.P.1
Ciro, M.2
Cocito, A.3
Helin, K.4
-
19
-
-
55549103719
-
E2F in vivo binding specificity: comparison of consensus versus nonconsensus binding sites
-
Rabinovich A., Jin V.X., Rabinovich R., Xu X., Farnham P.J. E2F in vivo binding specificity: comparison of consensus versus nonconsensus binding sites. Genome Res. 2008, 18:1763-1777.
-
(2008)
Genome Res.
, vol.18
, pp. 1763-1777
-
-
Rabinovich, A.1
Jin, V.X.2
Rabinovich, R.3
Xu, X.4
Farnham, P.J.5
-
20
-
-
70450285075
-
MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib
-
Bai S., Nasser M.W., Wang B., et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J. Biol. Chem. 2009, 284:32015-32027.
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 32015-32027
-
-
Bai, S.1
Nasser, M.W.2
Wang, B.3
-
21
-
-
48949091270
-
Activation of B-Myb by E2F1 in hepatocellular carcinoma
-
Nakajima T., Yasui K., Zen K., et al. Activation of B-Myb by E2F1 in hepatocellular carcinoma. Hepatol. Res. 2008, 38:886-895.
-
(2008)
Hepatol. Res.
, vol.38
, pp. 886-895
-
-
Nakajima, T.1
Yasui, K.2
Zen, K.3
-
22
-
-
53049092599
-
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer
-
Ladu S., Calvisi D.F., Conner E.A., Farina M., Factor V.M., Thorgeirsson S.S. E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer. Gastroenterology 2008, 135:1322-1332.
-
(2008)
Gastroenterology
, vol.135
, pp. 1322-1332
-
-
Ladu, S.1
Calvisi, D.F.2
Conner, E.A.3
Farina, M.4
Factor, V.M.5
Thorgeirsson, S.S.6
-
23
-
-
33846253532
-
SRF is a nuclear repressor of Smad3-mediated TGF-beta signaling
-
Lee H.J., Yun C.H., Lim S.H., et al. SRF is a nuclear repressor of Smad3-mediated TGF-beta signaling. Oncogene 2007, 26:173-185.
-
(2007)
Oncogene
, vol.26
, pp. 173-185
-
-
Lee, H.J.1
Yun, C.H.2
Lim, S.H.3
-
24
-
-
18344381018
-
Cyclin E in normal and neoplastic cell cycles
-
Hwang H.C., Clurman B.E. Cyclin E in normal and neoplastic cell cycles. Oncogene 2005, 24:2776-2786.
-
(2005)
Oncogene
, vol.24
, pp. 2776-2786
-
-
Hwang, H.C.1
Clurman, B.E.2
-
25
-
-
0038756442
-
Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma
-
Li K., Lin S.Y., Brunicardi F.C., Seu P. Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma. Cancer Res. 2003, 63:3593-3597.
-
(2003)
Cancer Res.
, vol.63
, pp. 3593-3597
-
-
Li, K.1
Lin, S.Y.2
Brunicardi, F.C.3
Seu, P.4
|